Prevalence and Epidemiology of Breast Cancer

 

World Health Organization (WHO), Breast Cancer - Fact Sheet, March 26, 2021, accessible at https://www.who.int/news-room/fact-sheets/detail/breast-cancer. 

 

Types of Breast Cancer

 

Acheampong T, Kehm RD, Terry MB, et al. (2020) Incidence Trends of Breast Cancer Molecular Subtypes by Age and Race/Ethnicity in the US From 2010 to 2016, JAMA Network Open, Original Investigation - Oncology, 3 (8): e2013226, accessible at

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2769316.

​

Pandit P, Patil R, Palwe V, Gandhe S, Patil R, and Nagarkar R (2020) Prevalence of Molecular Subtypes of Breast Cancer: A Single Institutional Experience of 2062 Patients, European Journal of Breast Health, 16 (1): 39–43, accessible at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939714. 

​

Gaoa JJ and Swain SM (2018) Luminal A Breast Cancer and Molecular Assays: A Review, The Oncologist, 23 (5): 556–565, accessible at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947456.

​

Li Z, Hu P, Tu J, and Yu N (2016) Luminal B breast cancer: patterns of recurrence and clinical outcome, Oncotarget, 7 (40): 65024–65033, accessible at

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323135.

​

Martínez-Sáez O, Prat A (2021) Current and Future Management of HER2-Positive Metastatic Breast Cancer, Journal for Clinical Oncology, Volume 17, Issue 10, accessible at https://ascopubs.org/doi/full/10.1200/OP.21.00172.

​

Schlam I, Swain SM (2021) HER2-positive breast cancer and tyrosine kinase inhibitors: the time is now, NPJ Breast Cancer, Volume 7, Number 56, accessible at https://www.nature.com/articles/s41523-021-00265-1. 

​

Toft DJ and Cryns VL (2011) Minireview: Basal-Like Breast Cancer: From Molecular Profiles to Targeted Therapies, Molecular Endocrinology, 25 (2): 199-211, accessible at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035993. 

​

Badve S, Dabbs DJ, Schnitt SJ, Baehner FL, Decker T, Eusebi V, Fox SB, Ichihara S, Jacquemier J, Lakhani SR, Palacios J, Rakha EA, Richardson AL, Schmitt FC, Tan PH, Tse GM, Weigelt B, Ellis IO, Reis-Filho JS (2011) Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists, Modern Pathology, Vol. 24, Pages 157-167, accessible at https://www.nature.com/articles/modpathol2010200.

​

Grades of Breast Cancer

​

Rakha EA, Reis-Filho JS, Baehner F, Dabbs DJ, Decker T, Eusebi V, Fox SB, Ichihara S, Jacquemier J, Lakhani SR, Palacios J, Richardson AL, Schnitt SJ, Schmitt FC, Tan PH, Tse GM, Badve S, and Ellis IO (2010) Breast cancer prognostic classification in the molecular era: the role of histological grade, Breast Cancer Research, 12 (4): 207, accessible at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949637.

​

Diagnosis and Treatment of Breast Cancer

​

The American College of Obstetricians and Gynecologists, ACOG (2017) Breast Cancer Risk Assessment and Screening in Average-Risk Women, Number 179 (Replaces Practice Bulletin Number 122, August 2011), Reaffirmed 2021, accessible at https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2017/07/breast-cancer-risk-assessment-and-screening-in-average-risk-women. 

​

Harnett A, Smallwood J, Titshall V, and Champion A (2009) Diagnosis and treatment of early breast cancer, including locally advanced disease—summary of NICE guidance, British Medical Journal (BMJ), 338: b438, accessible at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266859/.

​

Waks AG, Winer EP (2019) Breast Cancer Treatment - A Review, JAMA, 321 (3): pp. 288-300, accessible at https://jamanetwork.com/journals/jama/article-abstract/2721183. 

​

Moo TA, Sanford R, Dang C, and Morrow M (2018) Overview of Breast Cancer Therapy, PET Clinics, 13 (3): pp. 339–354, accessible at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092031/.